Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 7.93B 2.11B 1.9B 1.75B 1.59B 3B 198B 3.09B 20.91B 8.33B 106B 7.76B 336B P/E 2026 *
16.2x
P/E 2027 * 14.7x
Enterprise Value 7.6B 2.03B 1.82B 1.67B 1.52B 2.88B 190B 2.96B 20.05B 7.99B 102B 7.44B 322B EV / Sales 2026 *
4.61x
EV / Sales 2027 * 4.14x
Free-Float
38.61%
Yield 2026 *
3.51%
Yield 2027 * 3.87%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day+0.44%
1 week-0.26%
Current month-5.50%
1 month-11.48%
3 months-19.82%
6 months-27.70%
Current year-20.38%
1 week 112.8
Extreme 112.8
116.9
1 month 112.2
Extreme 112.2
126.6
Current year 112.2
Extreme 112.2
163.7
1 year 112.2
Extreme 112.2
163.7
3 years 102.4
Extreme 102.4
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 15/05/2021
Director of Finance/CFO 62 13/01/2013
Chief Operating Officer 31 01/09/2021
Director TitleAgeSince
Chairman 66 19/06/2022
Director/Board Member 41 19/06/2022
Director/Board Member 65 19/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.44%-0.26%-25.26%+6.69% 2.11B
+1.44%+1.63%+48.17%+139.63% 1,276B
-0.47%+5.49%+49.03%+90.68% 676B
+0.20%+2.76%+34.37%+112.06% 519B
+0.17%+2.76%+44.07%+69.71% 388B
-0.48%+2.34%+70.66%+46.02% 365B
+0.76%+2.27%+31.59%+60.36% 307B
-1.29%+0.90%+5.77%+37.60% 287B
0.00%+0.86%+43.74%+74.04% 252B
+0.92%+2.03%+44.62%+125.07% 212B
Average +0.02%+2.08%+34.68%+76.19% 428B
Weighted average by Cap. -0.09%+2.51%+43.68%+97.10%

Financials

2026 *2027 *
Net sales 1.65B 439M 394M 363M 330M 624M 41.19B 641M 4.35B 1.73B 22.07B 1.61B 69.76B 1.83B 487M 437M 403M 366M 692M 45.7B 712M 4.82B 1.92B 24.49B 1.79B 77.41B
Net income 491M 131M 117M 108M 98.13M 186M 12.26B 191M 1.29B 515M 6.57B 480M 20.76B 540M 144M 129M 119M 108M 205M 13.5B 210M 1.42B 568M 7.23B 529M 22.86B
Net Debt -326M -86.87M -77.9M -71.79M -65.2M -123M -8.14B -127M -860M -342M -4.36B -319M -13.79B -364M -96.99M -86.98M -80.16M -72.8M -138M -9.09B -142M -960M -382M -4.87B -356M -15.4B
Projected Income Statement - Annual - Jamjoom Pharmaceuticals Factory Company
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company is a Saudi Arabia-based entity which is primarily engaged in manufacturing, production, marketing, and distribution of pharmaceutical products. The Company is organized into two segments which are pharmaceutical products, consumer health products. Pharmaceutical products represent medicines or drugs, and they are essential for the prevention and treatment of diseases, and protection of public health; Consumer health products represent products used to support personal well-being, maintain health, or address specific health-related needs. The activities of the Company include producing human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. The Company operates approximately 7 branches in Saudi Arabia.
Employees
-
Date Price Change Volume
10/11/26 SAR 113.30 +0.44% 95,505
09/11/26 SAR 112.80 -0.88% 47,236
08/11/26 SAR 113.80 -0.35% 10,781
05/11/26 SAR 114.20 -0.52% 48,095
04/11/26 SAR 114.80 +1.06% 64,760
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Jamjoom Pharmaceuticals Factory Company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
113.30SAR
Average target price
152.16SAR
Spread / Average Target
+34.30%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Jamjoom Pharmaceuticals Factory Company
  1. Stock Market
  2. Stocks
  3. 4015 Stock